Invention Grant
- Patent Title: Readily isolated bispecific binding molecules with native format having mutated constant regions
-
Application No.: US14475892Application Date: 2014-09-03
-
Publication No.: US11261262B2Publication Date: 2022-03-01
- Inventor: Nicolas Fischer , Giovanni Magistrelli , Francois Rousseau , Krzysztof Masternak , Pauline Malinge
- Applicant: Novimmune S.A.
- Applicant Address: CH Geneva
- Assignee: Novimmune S.A.
- Current Assignee: Novimmune S.A.
- Current Assignee Address: CH Geneva
- Agency: Cooley LLP
- Agent Cynthia A. Kozakiewicz; Ivor R. Elrifi
- Main IPC: C07K16/46
- IPC: C07K16/46 ; C07K16/28 ; C07K16/24

Abstract:
The invention provides heterodimer bispecific antigen-binding molecules that include a first polypeptide that does not include an IgG CH1 domain and a second polypeptide where there is at least one mutation in the IgG CH3 domain that abolishes the ability of the second polypeptide to bind CH3-specific affinity media such that the first and second polypeptides have different affinities with respect to CH1 and CH3 specific affinity reagents that allows rapid isolation by differential binding. The invention also provides bispecific antibodies that have CH1 and CH3 regions with different affinities with respect to affinity reagents that allows rapid isolation by differential binding. The invention also concerns bispecific antibodies which are heterodimers of two IgG heavy chains that differ by at least two amino acids that allow for rapid isolation based on a differential affinity of one mutated heavy chain and a second mutated heavy chain toward two different affinity reagents.
Public/Granted literature
- US20150094451A1 Readily Isolated Bispecific Binding Molecules with Native Format Having Mutated Constant Regions Public/Granted day:2015-04-02
Information query